Prostate Cancer Treatment - CanAmHIFU

What is HIFU?

HIFU is an acronym that stands for High Intensity Focused Ultrasound. It is a therapy that destroys tissue with rapid heat elevation, which essentially “cooks” the tissue. Ultrasound energy, or sound waves, is focused at a specific location and at that “focal point,” temperature rises to almost 90 degrees Celsius in a matter of seconds. Any tissue at the focal point is destroyed; however, any tissue outside of the focal point remains unharmed. Unlike radiation, HIFU is non-ionizing so it can be repeated, if necessary, without damaging healthy tissue. HIFU is being studied around the world to treat all types of cancer and soft tissue diseases.

[ Back ]

Disclaimer

IMPORTANT INFORMATION:
The Sonablate® 500 is not approved for use in the U.S. The Sonablate® 500 remains investigational in the U.S. and is being studied for the treatment of prostate cancer in clinical trialsin the U.S. FDA has made no decision as to the safety or efficacy of the Sonablate® 500 for the treatment of prostate cancer. Currently, the device is approved for the treatment of prostate cancer in Canada and the Dominican Republic, authorized in Argentina, and available in the Bahamas and Mexico.
If the Sonablate® 500 is approved by the FDA for use in the U.S., there is no assurance that instructions for use or the specifications of the device will be the same as the device and treatment approved or authorized in other countries outside of the U.S.